Volv Global has been selected as a finalist in the 2026 Fierce AI Innovation Awards, in the category AI Innovation in Real-World Evidence & Data Analytics. The submission recognised in this category covers population-scale AI for real-world evidence generation and clinical trial enrichment across rare and difficult-to-diagnose diseases.
The Fierce AI Innovation Awards are run by Fierce Life Sciences Events and draw entries from across the healthcare and life sciences industry. This year’s panel of expert judges evaluated submissions on innovation, impact, execution, scalability, and industry relevance. Volv Global is among four finalists in the RWE and data analytics category, alongside Flatiron Health, Verantos, and Rune Labs.
